The University of Chicago Header Logo

Connection

Mark Lingen to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Mark Lingen has written about Antibodies, Monoclonal, Humanized.
Mark Lingen
Connection Strength
0.048
Antibodies, Monoclonal, Humanized
  1. Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximab. Cancer Gene Ther. 2024 Oct; 31(10):1477-1485.
    View in: PubMed
    Score: 0.036
  2. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 2010 Mar; 17(3):499-512.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.